In this episode, we are joined by Keith Bushfield. Keith is the CEO of Rexis Biotech, a company focused on developing innovative medical technologies. Prior to joining Rexis, Keith held various leadership positions in the biotechnology industry, including executive roles at popular companies such as Biogen and Genentech. Under his guidance, Rexis has made significant strides in the development of new treatments for various diseases, including cancer and neurological disorders.
Topics:
1. Cannabinoids As An Ingredient
2. Nanotechnology
* Twitter - @TheCannabisRev2
* LinkedIn - @thecannabisreview
* Episode Library - https://www.thecannabisreview.ie
+ Rexis Biotech https://rexissystems.com
